Pandemic influenza (H1N1) vaccines: Review [Pandemik i·nfluenza (H1N1) aşilari]

Küçük Resim Yok

Tarih

2011

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Erişim Hakkı

info:eu-repo/semantics/closedAccess

Özet

After started at March 2009 in Mexico, the pandemic influenza started to spread with rapidly in the world. World Health Organization (WHO) said that over 16000 people died from this infection. The Ministry of Health of Turkey announced 627 people died from pandemic influenza at 20 January 2010. H1N1 started to spread rapidly nearly pandemic, the vaccine research has been started and the vaccines developed. The pandemic influenza vaccines are non-adjuvanded, adjuvanded, and live attenuated vaccines. Since the application of pandemic influenza vaccine started swiftly, the community could not be informed sufficiently. Therefore, problems about application confronted. Squalene and thiomersal in adjuvanded vaccines and Guillain Barré syndrome (GBS) are the most discussed topics. Start of vaccination adverse effects and their activity is been observing and the studies are continuing, the vaccine several adverse effects have no difference of security profiles. Perspiration, erythema and pain on enjected area are the most seen side effects as predicted. Also these side effects healed without any treatment at short time. Fever, headache, fatigue, myalgia are reported as rarely side effects. These side effects healed without any treatment in 48 hours too. At this article, we purpose to give information about H1N1 vaccines which are using in Europe and USA. Copyright © 2011 by Türkiye Klinikleri.

Açıklama

Anahtar Kelimeler

Adjuvants, H1N1 subtype, Immunologic, Influenza A virus, Influenza vaccines

Kaynak

Turkiye Klinikleri Pediatri

WoS Q Değeri

Scopus Q Değeri

Q4

Cilt

20

Sayı

1

Künye